Jane Mounteney: EUDA, Europe's new drug watchdog Artwork

EURO HEALTH Podcast

The guests of this podcast are carefully selected professors, doctors and others, so as they are experts in the health sector and discuss a range of complex topics which should be debated by the European politicians in Brussels. The world is swelled by crises in the health sector but just a few get properly elaborated on. The EURO HEALTH Podcast is here to change the narrative and provide valuable perspectives on issues which might seem obsolete but are equally important as others. Moderated by Jan Klusáček.

All Episodes

EURO HEALTH Podcast

Jane Mounteney: EUDA, Europe's new drug watchdog

October 16, 2024 • Health Podcast • Season 3 • Episode 5

One of the world’s leading scientific hubs in the field of drugs and addiction is the European Monitoring Center for Drugs and Drugs Addictions (EMCDDA), which this summer acquired a new mandate and name, becoming the European Union Drugs Agency (EUDA). We asked Dr. Jane Mounteney, Head of the Public Health Union of the Agency, to guide us through this change.

The EMCDDA was born in the 1990s to face a health emergency in Europe, the heroine and HIV epidemics. Thanks to its incessant and high-quality scientific work, it became an internationally recognised authority in the field of drugs and addictions, and significantly impacted the sector’s landscape in the continent, also thanks to the introduction of approaches like harm reduction.

With respect to its predecessor, the EUDA acquired new responsibilities and a new mandate, such as a new focus on polydrug use and new tools for international and cross-border cooperation, while keeping collaborating with policymakers and civil society.

What are the reasons why the EMCDDA evolved into the EUDA? What changed in the drugs and drug addiction landscape in Europe in the last decades? What is the impact of the scientific and evidence-based approaches developed by the Agency, such as the harm reduction approach? How does the Agency intend to address new challenges, such as the combined consumption of licit and illicit drugs? Let Dr. Mounteney introduce you through this season of change in this episode of the Euro Health Podcast!

🗣SPEAKER

Dr. Jane Mounteney is the Head of the Public Health Union at the European Union Drugs Agency (EUDA).

She has been involved in drug research, policy, and practice since 1994. In 2010, Dr. Mounteney joined the EMCDDA, renamed EUDA following a revision of its mandate. In her role, she oversees key areas including epidemiology, policy, and practice related to drug use and its impact.

Throughout her career at the EUDA, Dr. Mounteney has been the lead writer on the European Drug Report and has published numerous scientific articles. Her work in this area has led to the establishment of various European and city-level systems and projects aimed at addressing these emerging challenges.

🎙 EURO HEALTH PODCAST

Euro Health Podcast focuses on European health policy by giving voice to leading experts. The goal is to bring complex and evidence-based information, which could lead to a better Europe. Podcast is hosted by Jiří Svoboda.

👀 FOLLOW US

Spotify: https://open.spotify.com/show/27oZmDwhNxNdWWW0IvqnVm?si=8e87042ce82d4a56

Apple Podcast: https://podcasts.apple.com/us/podcast/euro-health-podcast/id1573732306

X: https://x.com/EuroHealthP